The Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Enhance the Effects of Temozolomide Chemotherapy in Glioblastoma Cells
International Journal of Molecular Sciences · 09.09.2025 · 26 (18) · 8759
DOI: 10.3390/ijms26188759 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.09.2025. Verfasst von Janaína Alessandra Silva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Temozolomide, Eicosapentaenoic Acid, Glioblastoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Overcoming resistance to temozolomide (TMZ) chemotherapy is a major challenge in glioma treatment. Polyunsaturated fatty acids (PUFAs) can interfere with drug resistance in glioma but their mechanism of action is poorly understood. Eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) effects were assessed using proliferation and clonogenic assays, adhesion and migration assays, glucose and lactate metabolism, detection of lipid droplets, acidic vesicles, reactive oxygen species, and phosphokinase proteome analysis. EPA or DHA caused significant reductions in cell number, colony formation, adhesion, and migration in comparison with TMZ alone, increasing lipid droplet accumulation, reactive oxygen species formation, acidic vesicle number and apoptosis, while also altering glucose and lactate metabolism. TMZ increased phosphorylation of ERK 1/2, GSK3α/β, AMPKα1, Akt 1/2/3, PRAS40, CREB, HSP27, WNK1, and c-Jun in U87MG TMZR cells. EPA in the presence of TMZ reduced the phosphorylation of GSK3α/β, Akt 1/2/3, HSP27, and WNK1, while DHA reduced the phosphorylation of ERK 1/2, GSK3α/β, AMPKα1, Akt 1/2/3, and WNK1, thereby leading to additive or synergistic effects of EPA or DHA in combination with TMZ. Overall, the present study highlights the alterations seen in TMZ-resistant glioma cells when exposed to EPA or DHA and demonstrates the therapeutic potential that modulation of lipid metabolism can exert upon important aspects of glioma cell biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
ORCID-Profile: Janaína Alessandra Silva, Alison Colquhoun
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- FAPESP
Zitieren
APA
Silva, J. A., & Colquhoun, A. (2025). The Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Enhance the Effects of Temozolomide Chemotherapy in Glioblastoma Cells. International Journal of Molecular Sciences, 26(18), 8759. https://doi.org/10.3390/ijms26188759
Vancouver
Silva JA, Colquhoun A. The Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Enhance the Effects of Temozolomide Chemotherapy in Glioblastoma Cells. International Journal of Molecular Sciences. 2025;26(18):8759. doi:10.3390/ijms26188759
BibTeX
@article{Silva2025,
author = {Silva, Janaína Alessandra and Colquhoun, Alison},
title = {The Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Enhance the Effects of Temozolomide Chemotherapy in Glioblastoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {18},
pages = {8759},
doi = {10.3390/ijms26188759}
}
EUVIMED